- Heavy menstrual bleeding (clinically, menorrhagia or abnormal uterine bleeding) is common — affecting an estimated 1 in 5 women at some point — and it is almost always treatable.
- Any bleeding that soaks a pad or tampon every hour for several hours, passes clots larger than a quarter, lasts more than 7 days, or forces overnight changes is worth discussing with a clinician.
- Common causes include fibroids, polyps, adenomyosis, ovulation problems, thyroid disease, bleeding disorders such as von Willebrand disease, and some medications — evaluation sorts out which.
- Iron deficiency and anemia are frequent, under-recognized consequences and often explain the fatigue and breathlessness that women find most disabling.
- Treatment ranges from medications (including tranexamic acid and hormonal options) to a hormonal IUD to procedures; the right choice depends on the cause, your health, and your fertility plans, and is decided with a clinician.
- Seek emergency care for very heavy bleeding with dizziness, fainting, rapid heartbeat, or chest pain; otherwise, see a gynecologist for evaluation.
- What Heavy Menstrual Bleeding Is and How Common It Is
- Causes — The PALM-COEIN Framework
- Symptoms and Health Impact
- How Heavy Menstrual Bleeding Is Evaluated
- Treatment Options
- When to See a Doctor
- Frequently Asked Questions
- How much menstrual bleeding is too much?
- Can heavy menstrual bleeding cause anemia?
- Is the IUD a good option for heavy bleeding?
- Can heavy bleeding be a sign of cancer?
- The Bottom Line
- Sources
——————————————————————————–
Roughly 1 in 5 US women experiences heavy menstrual bleeding severe enough to affect daily activities at some point, yet many normalize their symptoms for years before seeking help. Beyond the disruption, prolonged heavy bleeding can cause iron deficiency, anemia, fatigue, and missed work or school. The older clinical term “menorrhagia” is still widely used, but clinicians increasingly describe the problem as “abnormal uterine bleeding” (AUB) and classify it with the FIGO PALM-COEIN system, which helps identify treatable causes and select the right therapy. The encouraging news is that heavy periods are common, rarely dangerous when evaluated promptly, and almost always treatable.
What Heavy Menstrual Bleeding Is and How Common It Is
Heavy menstrual bleeding is defined in research settings as blood loss greater than about 80 mL per cycle, but in everyday practice it is recognized by its impact: bleeding through pads or tampons roughly every hour, passing large clots, periods lasting more than 7 days, needing double protection, or having to change protection overnight. The American College of Obstetricians and Gynecologists notes that any bleeding pattern interfering with your physical, emotional, or social quality of life can be considered abnormal, regardless of the measured volume. Measuring milliliters at home is impractical, so how the bleeding affects your life matters more than any single number.
Public-health estimates suggest that millions of US women experience heavy menstrual bleeding each year, and prevalence appears to rise during perimenopause, when cycles often become irregular and ovulation less predictable. Despite how common the problem is, many women wait years before raising it with a clinician, often assuming heavy periods are simply normal for them. For broader context on related conditions, see our medical conditions hub.
Causes — The PALM-COEIN Framework
The FIGO PALM-COEIN classification organizes causes of abnormal uterine bleeding into structural (PALM) and non-structural (COEIN) categories. Structural causes include polyps, adenomyosis, leiomyomas (fibroids), and, less commonly, malignancy or hyperplasia. Non-structural causes include coagulopathy (bleeding disorders), ovulatory dysfunction, endometrial disorders, iatrogenic factors (such as anticoagulants, copper IUDs, or certain hormonal medications), and conditions not otherwise classified.
Inherited bleeding disorders — particularly von Willebrand disease — are found in a meaningful minority of women with heavy menstrual bleeding, with estimates commonly cited in the range of roughly 5 to 20 percent, especially when heavy periods have been present since the first period, per the CDC. Ovulatory dysfunction is one of the most common non-structural causes and accounts for many cases of heavy or irregular bleeding in adolescents and in women approaching menopause. Thyroid dysfunction, polycystic ovary syndrome, and elevated prolactin can all contribute, which is why an evaluation looks beyond the uterus itself. Because more than one factor can be present at once, a clinician’s job is often to weigh several possibilities rather than pin down a single cause.
Symptoms and Health Impact
Beyond the bleeding itself, women often describe fatigue, reduced exercise tolerance, shortness of breath on exertion, dizziness, hair thinning, restless legs, and difficulty concentrating — many of which reflect iron deficiency and anemia rather than the bleeding directly. Studies published in the obstetrics and gynecology literature report that a large share of women with heavy menstrual bleeding have iron deficiency, and a substantial minority develop anemia. These downstream effects are easy to miss because they build gradually, and they are one of the main reasons heavy bleeding deserves attention even when it feels “manageable.”
Heavy bleeding can also cause embarrassment, social withdrawal, missed work or school, effects on intimacy, and mood symptoms. Severe menstrual cramps often accompany heavy bleeding, particularly when fibroids or adenomyosis are present. Tracking your cycle — how many days you bleed, how often you change protection, and how you feel — gives a clinician useful information and can make a visit more productive.
How Heavy Menstrual Bleeding Is Evaluated
Evaluation usually starts with a focused history covering the bleeding pattern, age of onset, family history of bleeding, sexual and obstetric history, and current medications. A pelvic exam helps assess uterine size and tenderness. Initial labs often include a complete blood count and ferritin (to check for iron deficiency and anemia), a thyroid test, a pregnancy test, and, when bleeding has been heavy since the first period or is severe, tests for a bleeding disorder. These are general patterns; the exact workup is tailored to the individual.
Transvaginal ultrasound is commonly the first-line imaging test for women with persistent or unexplained bleeding. Saline infusion sonohysterography (adding fluid to the uterine cavity during ultrasound) can improve detection of polyps and submucosal fibroids. An endometrial biopsy — a sample of the uterine lining — is generally recommended for women 45 and older with abnormal uterine bleeding, and for younger women with persistent bleeding, risk factors for endometrial hyperplasia (such as obesity, polycystic ovary syndrome, or tamoxifen use), or imaging that suggests a problem in the lining, consistent with ACOG guidance. Which tests you need, and in what order, is a decision your clinician makes with you.
Treatment Options
Treatment depends on the cause, severity, your age, your other health conditions, and whether you want to preserve fertility — so the options below are educational, not a prescription. For many non-structural cases, medication is first-line. NSAIDs (such as ibuprofen or naproxen) can reduce blood loss and help with cramping. Tranexamic acid (brand name Lysteda in the US) is a non-hormonal medicine taken only during menstruation that reduces blood loss; it is FDA-approved specifically for heavy menstrual bleeding. Reported reductions in bleeding vary across studies, and it is not appropriate for everyone — for example, people at higher risk of blood clots — which is one reason it is prescribed and monitored by a clinician.
Hormonal options include combined hormonal contraceptives (pill, patch, or ring), progestin-only options, and especially the levonorgestrel-releasing IUD. The 52-mg levonorgestrel IUD (Mirena is FDA-approved for heavy menstrual bleeding) substantially reduces menstrual blood loss for many users and is often considered a first-line option, including for some women with adenomyosis or fibroids that do not significantly distort the uterine cavity. For heavy bleeding caused by fibroids, GnRH antagonist combination pills (such as relugolix or elagolix combined with add-back hormones) are FDA-approved and may be considered in specific situations. Not every option suits every person, and effectiveness varies with the underlying cause.
Procedural options may be considered when medication is not enough or not appropriate, and include endometrial ablation, uterine artery embolization (for fibroid-related bleeding), and hysteroscopic or surgical removal of polyps or fibroids (polypectomy or myomectomy). Iron supplementation is important when iron deficiency or anemia is present; oral iron is usually first-line, and intravenous iron is sometimes used when oral iron is poorly tolerated or not working well. Hysterectomy can be a definitive option for women who have completed childbearing and have symptoms that have not responded to other treatments, but it is a major surgery reserved for specific situations. Which of these is right — if any — is a shared decision made with a gynecologist.
When to See a Doctor
Consider scheduling a visit if you soak through a pad or tampon every hour for several consecutive hours, pass clots larger than a quarter, bleed for more than 7 days, need to wake at night to change protection, or have bleeding between periods or after intercourse. Symptoms that may point to anemia — persistent fatigue, shortness of breath, or a racing heartbeat — alongside heavy periods are worth prompt evaluation.
Some bleeding patterns deserve particularly prompt assessment because they can signal a problem with the uterine lining. These include any bleeding after menopause, bleeding between periods (especially after age 35), and bleeding in women with risk factors for endometrial cancer such as obesity, diabetes, polycystic ovary syndrome, or estrogen exposure that is not balanced by progesterone. Most causes of heavy bleeding are benign, but these situations are a reason to be seen rather than to wait.
When to seek emergency care: Call 911 or go to the nearest emergency room if you are bleeding through more than one pad or tampon per hour for two or more consecutive hours, or if heavy bleeding is accompanied by dizziness or fainting, a rapid heartbeat, chest pain, severe shortness of breath, or other signs of dangerous blood loss. These can indicate hemorrhage that needs urgent care.
Frequently Asked Questions
How much menstrual bleeding is too much?
Soaking through pads or tampons about every hour for several hours, passing clots larger than a quarter, periods lasting more than 7 days, or needing double protection or overnight changes all suggest abnormally heavy bleeding. How much it disrupts your life matters more than any exact volume, so it is reasonable to raise it with a clinician even if you are unsure.
Can heavy menstrual bleeding cause anemia?
Yes, frequently. Iron deficiency is common with heavy bleeding and can progress to anemia. Symptoms include fatigue, shortness of breath, hair thinning, and difficulty concentrating. Treating the underlying cause along with correcting iron levels typically improves both, but the right approach is individualized and worth discussing with a clinician.
Is the IUD a good option for heavy bleeding?
For many people, the 52-mg levonorgestrel-releasing IUD substantially reduces menstrual blood loss, and one version (Mirena) is FDA-approved specifically for heavy menstrual bleeding. It is often considered first-line, including for some women with adenomyosis or fibroids that do not significantly distort the uterine cavity. Whether it fits your situation is a decision to make with your clinician.
Can heavy bleeding be a sign of cancer?
Most cases are not cancer. However, endometrial hyperplasia and endometrial cancer can cause abnormal bleeding, and the risk rises with age, obesity, polycystic ovary syndrome, diabetes, and unopposed estrogen exposure. An endometrial biopsy is generally recommended for women 45 and older with abnormal bleeding and for younger women with risk factors — another reason evaluation is worthwhile.
Quick summary: Heavy menstrual bleeding (menorrhagia) means periods heavy or prolonged enough to affect your life, and it is common and usually treatable. Causes range from fibroids, polyps, and adenomyosis to ovulation problems, thyroid disease, bleeding disorders, and some medications. Effective options exist — from medications such as tranexamic acid and hormonal treatments to a hormonal IUD and procedures — but the right choice depends on the cause and your health and is decided with a clinician. Seek emergency care for very heavy bleeding with dizziness, fainting, a racing heart, or chest pain. This article is educational and not a substitute for care from a qualified clinician.
The Bottom Line
Heavy menstrual bleeding is common, often dismissed, and almost always treatable. Modern medical options — particularly the levonorgestrel IUD, tranexamic acid, and, for fibroid-related bleeding, GnRH antagonist combinations — give many women effective non-surgical control. Iron deficiency deserves attention even while the bleeding is being treated, because it accounts for many of the symptoms women find most disabling. A gynecologist familiar with current PALM-COEIN-based evaluation can help match therapy to your underlying cause and life stage. If heavy periods are affecting your life, that is reason enough to be seen.
Sources
- American College of Obstetricians and Gynecologists (ACOG) — Heavy Menstrual Bleeding and abnormal uterine bleeding guidance.
- MedlinePlus (U.S. National Library of Medicine) — heavy menstrual bleeding and menorrhagia.
- Centers for Disease Control and Prevention (CDC) — Heavy Menstrual Bleeding; von Willebrand disease and women.
- U.S. FDA / DailyMed — labeling for tranexamic acid (Lysteda) and the levonorgestrel 52 mg intrauterine system (Mirena) for heavy menstrual bleeding.
- FIGO PALM-COEIN classification of abnormal uterine bleeding (Munro MG et al.).
This article is for general education and is not medical advice. It does not include specific medication doses or self-treatment instructions. Talk with a qualified clinician about evaluation and treatment for your situation.
